 |
Telegraph (November 18, 2015) A screening test with a 90 per cent accuracy rate for detecting potentially fatal ovarian cancer early is a major step closer. Studying blood serum compounds led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer. Early diagnosis is vital for treatment of ovarian cancer. |